Hidden fat lumps may sabotage insulin: new study investigates
NCT ID NCT02748434
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether small, hard-to-see fat lumps under the skin (called subclinical lipohypertrophy) change how insulin is absorbed in people with diabetes. Researchers planned to enroll 20 adults with type 1 or type 2 diabetes who use insulin and had these hidden lumps. They measured blood sugar levels using continuous glucose monitors to see if injecting insulin into these areas affects glucose control. The study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gerontology Research Lab
Vancouver, British Columbia, V5Z 1M9, Canada
-
Vancouver General Hospital Diabetes Centre
Vancouver, British Columbia, V5Z 1M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- FitBit coaching may help amputees walk more after surgery
- Can AI catch the leading cause of blindness before It's too late?
- Does feeling stigmatized worsen life quality for men with low testosterone?
- Can community hospitals in zambia master severe disease care?
- Can a wearable sensor beat Finger-Prick tests for type 2 diabetes?
- Brain training may sharpen aging minds in diabetes